Polyomavirus and papillomavirus (papovavirus) capsids are composed of 72 capsomeres of their major capsid protein, VP1 and L1 respectively. After translation in the cytoplasm, L1 and VP1 pentamerize into capsomeres and are then imported into the nucleus using the cellular α and β karyopherins. Virion assembly only occurs in the nucleus and cellular mechanisms exist to prevent premature capsid assembly in the cytosol. We have identified the karyopherin family of nuclear import factors as possible "chaperones" in preventing the cytoplasmic assembly of papovavirus capsomeres.
control mechanism may involve the hsc70 family of cellular chaperone proteins. For example, in mouse cells infected with polyomavirus, hsp70 binds polyomavirus VP1 in the cytoplasm and co-localizes with VP1 after transport into the nucleus (9) . Moreover, in vitro capsid assembly of polyomavirus VP1 capsomeres is inhibited by bound hsc70 (7) .
We have investigated a potential role for karyopherins as chaperones of mPy VP1 and HPV11 L1 capsid assembly. We show that the NLS sequences of both mPy VP1 and HPV 11 L1 are required for binding karyopherins α2β1. Karyopherins affected the DNA binding properties of HPV 11 L1 but not mPy VP1. In vitro, both HPV11 L1 and mPy VP1 capsid assembly was inhibited in the presence of karyopherins α2β1. We propose that karyopherins play a chaperone function in the papovavirus life cycle by inhibiting capsid formation in the cytoplasm while importing L1 and VP1 capsomeres into the nucleus.
Methods

Preparation of recombinant proteins
Recombinant full-length HPV11 L1, mPy VP1, truncated HPV11 L1 (C∆29), and truncated mPy VP1 (N∆6) were expressed as GST fusion protein in BL21 (DE3) E. coli cells. Cells were grown at 37 o C in 2xYT medium plus ampicillin to an OD 600 of ~0.2, then cooled to 25 o C and induced with 1.0 mM IPTG for 15 h. Cells were harvested by centrifugation followed by resuspension in buffer L (40 mM Tris-HCl pH 8.0, 0.2 M NaCl, 5% glycerol, 1 mM EDTA, 5 mM DTT) with protease inhibitors 1.25 ug/ml pepstatin, 2 ug/ml leupeptin and 1 mM PMSF. Cells were lysed by adding 0.5 mg/ml lysozyme and 0.1% deoxycholic acid and incubated at room temperature for 1 h. Lysate was treated with 10 /ml DNase I and 5 mM MgCl 2 and incubated at 4°C with gentle shaking 4-5 h. Recombinant full-length His-tagged karyopherin α2 (48), GST-tagged and His-tagged karyopherin β1 (5) were prepared as previously described. The purified proteins were dialyzed in buffer A (20 mM HEPES-KOH, pH 7.3, 110 mM potassium acetate, 2mM magnesium acetate, 2mM dithiothreitol) containing protease inhibitors.
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Karyopherin β β β β1 binding to α α α α2 and capsid protein VP1 or L1.
Glutathione-sepharose 4B beads (Amersham) were pre-incubated with buffer A (20 mM HEPES-KOH pH 7.0, 100 mM potassium acetate, 2 mM magnesium acetate, 0.1 % Triton X-100, 2mM EGTA, 1 mM DTT) supplemented with 1% BSA for 1 h at room temperature (RT) followed by 3 washes in buffer A. Recombinant GST-β1 protein was immobilized on BSA blocked glutathione-sepharose 4B beads (1.5 µg of protein/10 µg of beads) and incubated for 30 min at (RT) with 1.5 µg mPy VP1 or HPV11 L1 with α2 in buffer A. To control for non-specific binding of karyopherins to the GST protein moiety or the glutathione sepharose beads, 1.5 µg GST protein was immobilized on BSA blocked glutathione-sepharose 4B beads and incubated with 1.5 µg mPy VP1 or HPV11 L1 with α2 in buffer A. GST-L1 binding to karyopherins α2 and β1 was also performed as described above for GST-β1. Bound protein was washed in buffer A with 0.3 % Triton X-100. The bound proteins were eluted from the sepharose beads by boiling in Laemmli buffer (2% (w/v) SDS, 10% glycerol, 60 mM Tris-HCl (pH 6.8), 5% β-mercaptoethanol, EDTA pH 8.0). DNA bands were imaged using a UV light source. After EMSA of L1 or VP1 DNA protein complexes in 0.8% agarose gels as described above, the gels were soaked for 15 min in transfer buffer (25 mM Tris, 200 mM glycine, and 10% methanol).
Proteins were transferred to immobilon-P (Millipore) using a semi-dry transfer apparatus In vitro assembly reactions.
In vitro assembly reactions were performed using recombinant mPy VP1 or HPV11 L1 capsid proteins at 150 µg/ml. 50 µl of VP1 or L1, diluted to 150 µg/ml in (20 mM HEPES-KOH pH 7.0, 110 mM KCl, 2 mM MgCl 2 ) were dialyzed in mini-dialysis units (molecular weight cut-off 3,500; Pierce) against assembly buffer (50 mM Tris·HCl, 150 mM NaCl, 0.5 mM CaCl 2 , 5% glycerol, pH 7.2) at RT overnight. Assembly reactions were concentrated to 50 µl using a Microcon 0.5 ml concentrator (Millipore). 50 µl drops were spotted onto parafilm and then absorbed to glow-discharged, carbon and formvarcoated copper transmission electron microscopy (TEM) grids (G400 copper, EM Science). Grids were blotted dry on Kimwipe (Kimberly-Clark) followed by staining with uranyl acetate (2% w/v), and TEM (Philips CM10) at 80 kV. The number of 50 nm particles was determined by direct count of the indicated number (n = 6) of grid squares (1,369 µm 2 ) at 4,800x magnification. To test assembly inhibition by karyopherins, α2, β1, or α2β1, karyopherin proteins were added to the capsid proteins at 1:3 molar concentration relative to the VP1 or L1 protein concentration followed by dialysis and capsid formation assessed using TEM as described above. proteins are bound by a heterodimer of αβ karyopherins (31, (37) (38) (39) . The NLS of mPy VP1 is located at its amino-terminus in contrast to HPV11 L1 where the NLS is situated at the carboxyl-terminus (Fig. 1A) . To determine whether karyopherins specifically interact with the NLS of mPy VP1 pentamers, both the full-length recombinant VP1
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protein and a recombinant VP1 protein lacking the NLS (VP1N∆6) were incubated with karyopherins α2 and GST-β1. Proteins bound to GST-β1 were detected by glutathione sepharose chromatography followed by SDS-PAGE. As shown in Proteins can localize to the nucleus in a karyopherin α-independent, β-dependent manner (22, 34, 47) . Because karyopherin β1 alone inhibited the association of HPV11
L1 capsomeres with DNA, the interaction between β1 and L1 was investigated by immuno-blot of the proteins associated with DNA after EMSA. HPV11 L1 capsomeres alone or bound by karyopherins α2, β1, or α2β1 were subsequently incubated with plasmid DNA and the resultant complexes resolved by agarose gel electrophoresis.
Consistent with the HPV11 L1 DNA binding experiment shown in Fig. 2B , the addition of karyopherin α2 alone to the L1-DNA complex resulted in a DNA super-shift whereas addition of karyopherin β1 alone or α2β1 completely inhibited L1 DNA binding ( β1 or L1 and α2β1 was observed in the lanes were DNA was no longer bound by L1 (Fig. 2C , anti-L1, anti-α2, and anti-β1 panels). In contrast to the formation of an L1+α2+DNA complex, these data suggest that when karyopherins β1 or α2β1 bind L1, L1 is subsequently unable to bind DNA. While a significant amount of DNA is released from L1 with the addition of karyopherins β1 or α2β1 to the DNA binding reaction, it is possible that some DNA remains associated with L1 accounting for the L1 migration pattern shown in Fig. 2C . Western blot analysis of HPV11 L1 incubated with or without
DNA followed by agarose gel electrophoresis demonstrated that the migration of L1 in native agarose gels was not altered when DNA was present in the binding reaction (not shown).
To further validate the interaction between karyopherin β1 and HPV11 L1, full-length recombinant L1 protein fused to GST was incubated with karyopherins α2, β1, or α2β1.
Proteins bound to GST-L1 were detected by SDS-PAGE followed by western blot analysis using antibodies against HPV11 L1, karyopherins α2 or β1. As shown in Fig.   2D , GST-L1 bound karyopherin α2 and the α2β1 heterodimer. Interestingly, GST-L1 was also capable of binding β1 independent of α2.
mPy VP1 and HPV11 L1 capsomeres can bind karyopherin α α α α2 and DNA simultaneously.
Our initial experiments showed that karyopherin α2 (0.5 µM) did not inhibit DNA (6.9 nM) binding by either mPy VP1 or HPV11 L1 (2.6 µM) capsid proteins. Because the amino acid sequence comprising the NLS of mPy VP1 and HPV11 L1 overlaps their DNA binding domain we tested whether binding karyopherin α2 would inhibit DNA binding when α2 is in molar excess relative to VP1 or L1. Karyopherin α2, ranging from equal molar up to a 16 fold molar excess relative to the capsid protein monomer, was pre-incubated with either mPy VP1 or HPV11 L1 protein prior to addition of plasmid DNA ( Fig. 3A and B) . The resultant DNA protein complexes were then resolved by agarose gel electrophoresis. A decrease in the mobility of the VP1 or L1 plasmid DNA complex was observed when the capsid protein (2.6 µM) was bound with an equal molar amount of karyopherin α2 (Fig. 3A and B, compare lanes 2 and 3) . Increasing the amount of karyopherin α2 added to the binding reaction from a 2 fold to 16 fold molar excess relative to the capsid protein concentration further decreased the mobility of the
nucleoprotein complex corresponding to the amount of α2 added to the reaction (Fig. 3A and B). These results suggest that karyopherin α2 binding to VP1 or L1 capsomeres was insufficient to disrupt DNA binding and that mPy VP1 or HPV11 L1 capsomeres can bind karyopherin α2 and DNA simultaneously.
DNA competes for karyopherin α α α α2 binding to VP1 and L1.
It is currently unknown when karyopherin α disassociates from the capsid proteins after nuclear import. One possibility is that the "NLS-like" sequences at the aminoterminus of karyopherin α compete the karyopherin from the VP1 or L1 NLS (17, 18) .
Alternatively, because their DNA binding domain overlaps their NLS, binding DNA to VP1 or L1 may release α2 from the NLS. The results shown in Fig. 3 suggested that VP1 and L1 can form a nucleoprotein complex that includes the capsid protein, karyopherin α2, and DNA, as evidenced by the slower migrating complex. We tested whether increasing the DNA concentration in the DNA binding reaction containing VP1
and karyopherin α2 could compete α2 from the nucleoprotein complex. VP1 (2.6 µM)
was first incubated with the karyopherin α2 (0.5 µM) and linearized plasmid DNA (6.9nM). In an attempt to compete α2 from the nucleoprotein complex, 60 base-pair duplex oligonucleotides were then added to the binding reaction to a final concentration of 3, 6, 12, or 24 µM. The migration of the nucleoprotein complex containing plasmid DNA was assessed by agarose gel electrophoresis. As shown in Fig. 4A , the oligonucleotides competed VP1 and α2 binding to plasmid DNA when the concentration of oligonucleotides was 6 µM or greater as determined by the migration of the plasmid DNA in the agarose gel (Fig. 4A, compare lanes 3 and 5) . Interestingly, the nucleoprotein complex from the reaction containing 3 µM oligonucleotide migrated to the same position as the nucleoprotein complex containing VP1 and plasmid DNA (Fig. 4A, Similar results were also observed for HPV11 L1 (data not shown). The competition between DNA and karyopherin α2 binding to VP1 capsomeres was further analyzed by titrating the concentration of oligonucleotides into the binding reaction from 3 µM to 5 µM (Fig. 4B ). As shown in Fig 4B, karyopherin α2 was competed from the nucleoprotein complex with the addition of oligonucleotide DNA ranging from 3-5 µM (Fig. 4B , compare lanes 2 and 4-7). We interpret these results to suggest that DNA is able to compete karyopherin α2 from the VP1 NLS.
Karyopherin binding inhibits in vitro capsid assembly of VP1 and L1 capsomeres.
The subcellular location of papovavirus assembly is controlled such that virions are formed in the cell nucleus and not in the cytoplasm (13, 33) . The hsp70 family of proteins has been shown to bind polyomavirus VP1 and implicated in regulating polyomavirus capsid assembly (7, 9) . Karyopherin proteins associate with VP1 capsomeres in the cytoplasm and remain associated with the capsomeres as they localize to the nucleus. Therefore a potential role for karyopherins in inhibiting mPy VP1 capsid formation has been tested. In vitro calcium-mediated assembly of polyomavirus VP1 capsomeres was used as an assay to test factors that bind VP1 capsomeres in vivo may affect assembly (7). Assembly reactions with mPy VP1 were performed in the presence or absence of karyopherins α2, β1, or α2β1 by overnight dialysis in assembly buffer containing 0.5 mM calcium chloride. The VP1 concentration did not change during dialysis as detected by soluble protein concentration. The samples were then analyzed
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on October 22, 2017 by guest http://jvi.asm.org/ Downloaded from by transmission electron microscopy (TEM). VLPs were counted using six images per grid from four independent experiments. VP1 assembled into T=7 particles in the absence of karyopherins, but not in the presence of the α2β1 heterodimer (Fig. 5A ). VP1 also assembled into T=7 particles in the presence of either α2 or β1 karyopherins alone (Fig. 5B) . Quantitation of assembled particles demonstrated that calcium-mediated in vitro assembly of VP1 VLPs was reduced by more than 20 fold in the presence of karyopherins α2β1 (Fig. 5C ).
In vitro assembly of papillomavirus L1 capsomeres was used to assess the effects of karyopherins on papillomavirus capsid assembly. Assembly reactions were performed with L1 in the presence or absence of karyopherins α2, β1, or α2β1 followed by an overnight dialysis in assembly buffer that allowed formation of interpentameric disulfide bonds. As observed with VP1 capsomeres, L1 capsomeres assembled into T=7 particles in the absence of karyopherins, but not in the presence of the α2β1 heterodimer (Fig. 6A) . In contrast to VP1, we also observed an inhibition of L1 particle assembly in the presence of α2 (Fig. 6B) . Additionally, we observed a shift towards the formation of T=1 and T=3 particles in assembly reactions containing L1 and β1.
Quantitation of assembled particles demonstrated that assembly of L1 capsids was reduced by more than 15 fold in the presence of karyopherins α2β1 (Fig. 6C) .
Individually, α2 inhibited L1 capsid assembly by 3 fold (Fig. 6C) .
Discussion
In order to determine whether karyopherin binding to papovavirus capsid protein affects capsid assembly, the interaction between karyopherins and the HPV11 L1 or mPy VP1 capsid proteins was investigated. As previously observed for the L1 capsid
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on October 22, 2017 by guest http://jvi.asm.org/ Downloaded from proteins of HPV11 and HPV45 (38) , the HPV11 L1 capsid protein bound both karyopherins α2 and α2β1. mPy VP1 also interacted with karyopherins α2 and α2β1.
The interaction between karyopherins and L1 or VP1 was dependent on an intact NLS (Fig. 1) .
Nuclear import of proteins that contain a canonical NLS, such as mPy VP1 and HPV11 L1, occurs by binding the adapter protein karyopherin α2 to the NLS that then recruits karyopherin β. An alternative pathway for nuclear import utilizes karyopherin β without the adapter protein karyopherin α (22, 34, 47) . Although HPV11 L1 capsomeres interact with karyopherin α2 or the α2β1 heterodimer in an NLS dependent manner, L1
capsomeres also interacted with karyopherin β1 in the absence of karyopherin α2 (Fig.   2 ). Moreover, karyopherin β1 strongly inhibited DNA binding by L1 capsomeres, suggesting that the interaction of L1 with karyopherin β1 competes for L1 binding to DNA. However, it is unclear whether L1 binding by β1 alone is biologically significant or restricted to an in vitro association. Our current understanding of L1 import suggests that karyopherin β1 would not be present in the nucleus to inhibit the interaction between L1 capsomeres and DNA. More work is needed to evaluate the potential significance of the interaction between HPV11 L1 and karyopherin β1 in vivo.
Karyopherin-mediated nuclear import may also be important during the initial phase of virus infection when viral nucleoprotein complexes, composed of capsid proteins bound to the viral genome, exits a membrane compartment (the endosome for papillomavirus or the endoplasmic reticulum for polyomavirus) into the cytoplasm (11, 16) . In the cytoplasm, karyopherins may bind the exposed NLS(s) of capsomeres or the minor capsid proteins, which are bound to the viral DNA, and then transport the viral
on October 22, 2017 by guest http://jvi.asm.org/ Downloaded from protein complex into the nucleus. In order for this transport pathway to function, capsomeres must be able to bind the viral genome and karyopherins simultaneously.
We found that VP1 (2.6 µM) complexed with karyopherin α2 (0.5 µM) was able to bind plasmid DNA (6.9 nM). Additionally, increasing α2 to a 16 fold molar excess over the capsid protein lead to slower migration of the DNA protein complex by EMSA (Fig. 3) .
We interpret these results to mean that the five DNA binding domains of a VP1
pentamer are not fully occupied by DNA, because unoccupied NLSs continued to bind α2. However the gel mobility of the complex also indicated that the interaction between karyopherin α2 and the NLSs of mPy VP1 was insufficient to displace DNA from the DNA binding domain. These data suggest that in vitro, a pentamer bound to plasmid DNA does not have all five DNA binding domains of the pentamer in contact with the DNA. However, during infection the polyomavirus genome is configured with nucleosomes and how the DNA binding domain of VP1 or L1 will interact with nucleosome bound DNA is unclear.
Similar to the results of mPy VP1, we found that HPV11 L1 (2.6 µM) complexed with karyopherin α2 (0.5 µM) was able to bind plasmid DNA (6.9 nM). Additionally, increasing α2 to a 16 fold molar excess over the capsid protein lead to slower migration of the DNA protein complex by EMSA (Fig. 3) . However, DNA binding by HPV11 L1
capsomers was inhibited by karyopherin α2β1 (Fig. 2B ) and karyopherin α2 cannot alone mediate nuclear import in the absence of β1 import receptor. These results suggest that it is unlikely that HPV11 L1 mediates import of the viral genome during the initial phase of infection as L1 binding of karyopherin α2β1 in the cytoplasm would release the viral DNA from the capsid protein prior to being transported into the nucleus.
Consistent with this reasoning, L1 has not been detected in the nucleus in the initial for DNA may reflect a greater dependence on the viral L2 protein to bind the viral genome and serve as an interface for encapsidation.
As the capsomeres enter the nucleus, RanGTP dissociates karyopherin β from the cargo protein complex. However, what mediates the dissociation of karyopherin α from the capsid proteins is unknown. One possibility is that DNA binding to VP1 or L1 releases α2 from the NLS. We observed that addition of oligonucleotide DNA ranging from 3-6 µM to a nucleoprotein complex composed of capsid protein (2.6 µM), karyopherin α2 (0.5 µM) and plasmid DNA (6.9 nM) was able to compete karyopherin α2 from the NLS of mPy VP1 (Fig 4B) . These data raise the possibility that in the nucleus, the viral DNA may displace karyopherin α2 from the capsid protein allowing for capsid assembly around viral genome.
The mPy VP1 and HPV11 L1 capsid proteins have the intrinsic ability to selfassemble in vitro and in vivo. Given these intrinsic self-assembly properties there must be biological controls in vivo that regulate the quality and subcellular location of viral capsid assembly. The hsp70 family of chaperones previously has been shown to modulate assembly and disassembly of polyomavirus and papillomavirus capsid protein (6, 7) . Our data suggests that another potential mechanism for modulating capsid assembly may involve the karyopherin proteins that bind the NLS of HPV11 L1 and mPy VP1, and that karyopherin proteins may have "chaperone" functions. The karyopherin heterodimer α2β1 inhibited in vitro assembly of both HPV11 L1 and mPy VP1.
Karyopherin α2β1 heterodimers (157.5 kDa complex) bind HPV11 L1 at the NLS located at the carboxyl-terminus of the protein. Binding to the carboxyl-terminus may inhibit assembly through steric inhibition, because the L1 carboxyl-terminus is also used for inter-pentamer bonding (25, 32) . Karyopherin α2 also had an inhibitory effect on L1
assembly, although to a lesser extent than α2β1. This finding supports the idea that steric hindrance may inhibit assembly and that by recruiting β1 to the L1 + α2 complex assembly is further inhibited. Interestingly, karyopherin β1 appeared to shift assembly in favor of the T=3 and T=1 products. These data suggest that β1 may interact with the carboxyl-terminus of L1 and alter the inter-pentamer contacts mediated by the carboxylterminal domain. The NLS of VP1 is located at its amino-terminus, which for SV40 is involved in inter-pentamer contacts through the formation of disulfide bonds (43) .
Binding of karyopherins α2β1 to the VP1 amino-terminus may prevent these inter- (n = 5) from three independent assembly reactions. Scale bar is 1µm at 4800x and 100nm at 49000x.
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